Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SPCX
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DHC
3276
Diversified Healthcare Trust
DHC
$1.85B
| $16.1M | ﹤0.01% |
1,728,981
+327,379
| +23% | +$2.68M |
|
|
AMBQ
3277
Ambiq Micro
AMBQ
$1.39B
| $16.1M | ﹤0.01% |
182,007
+150,602
| +480% | +$8.92M |
|
3278
iShares Global Consumer Discretionary ETF
RXI
$270M
| $16M | ﹤0.01% |
83,035
-4,032
| -5% | -$792K |
|
3279
NCR Voyix
VYX
$1.21B
| $16M | ﹤0.01% |
1,954,630
+538,285
| +38% | +$3.79M |
|
3280
Tango Therapeutics
TNGX
$3.94B
| $16M | ﹤0.01% |
510,778
-966,710
| -65% | -$23.9M |
|
3281
Absci
ABSI
$1.49B
| $15.9M | ﹤0.01% |
1,374,693
+888,068
| +182% | +$5M |
|
3282
Blue Bird Corp
BLBD
$1.88B
| $15.9M | ﹤0.01% |
201,359
-63,574
| -24% | -$4.32M |
|
|
MICC
3283
The Magnum Ice Cream Company N.V.
MICC
$12.3B
| $15.9M | ﹤0.01% |
912,786
+171,640
| +23% | +$2.67M |
|
3284
State Street SPDR S&P 1500 Value Tilt ETF
VLU
$782M
| $15.9M | ﹤0.01% |
66,710
+10,994
| +20% | +$2.55M |
|
3285
Columbia Diversified Fixed Income Allocation ETF
DIAL
$396M
| $15.8M | ﹤0.01% |
871,399
-17,332
| -2% | -$315K |
|
3286
Janus Henderson Securitized Income ETF
JSI
$1.54B
| $15.8M | ﹤0.01% |
308,876
-756
| -0.2% | -$39K |
|
3287
Northern Trust Ultra-Short Fixed Income ETF
RAVI
$1.52B
| $15.8M | ﹤0.01% |
209,083
+39,427
| +23% | +$2.97M |
|
3288
Tompkins Financial
TMP
$1.41B
| $15.8M | ﹤0.01% |
166,711
-480
| -0.3% | -$41.3K |
|
3289
Paymentus
PAY
$4.53B
| $15.7M | ﹤0.01% |
651,822
+412,709
| +173% | +$10.1M |
|
|
TRAX
3290
First Tracks Biotherapeutics
TRAX
$1.5B
| $15.7M | ﹤0.01% |
+781,534
| New | +$14.6M |
|
3291
WisdomTree Trust WisdomTree Interest Rate Hedged High Yield Bond Fund
HYZD
$294M
| $15.7M | ﹤0.01% |
698,232
+8,411
| +1% | +$190K |
|
3292
Bain Capital Specialty
BCSF
$774M
| $15.7M | ﹤0.01% |
1,254,889
+108,756
| +9% | +$1.42M |
|
3293
State Street SPDR Portfolio MSCI Global Stock Market ETF
SPGM
$1.75B
| $15.7M | ﹤0.01% |
183,094
+12,449
| +7% | +$1.04M |
|
|
NTSK
3294
Netskope Inc
NTSK
$6.1B
| $15.7M | ﹤0.01% |
1,432,894
-398,222
| -22% | -$4.06M |
|
3295
EVgo
EVGO
$196M
| $15.7M | ﹤0.01% |
8,205,206
-973,570
| -11% | -$1.96M |
|
3296
BlackRock Health Sciences Trust
BME
$593M
| $15.7M | ﹤0.01% |
364,745
+6,827
| +2% | +$271K |
|
|
DBVT
3297
DBV Technologies
DBVT
$851M
| $15.7M | ﹤0.01% |
954,908
+808,792
| +554% | +$15.3M |
|
3298
Sportradar
SRAD
$3.83B
| $15.7M | ﹤0.01% |
1,045,834
-1,074,378
| -51% | -$15.6M |
|
3299
The RMR Group
RMR
$332M
| $15.7M | ﹤0.01% |
762,493
-174,527
| -19% | -$3.3M |
|
3300
JPMorgan BetaBuilders MSCI US REIT ETF
BBRE
$1.27B
| $15.7M | ﹤0.01% |
145,917
+16,554
| +13% | +$1.72M |
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 423 new, 3,809 increased, 3,216 reduced and 305 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 423 new positions and closed 305 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.